According to study, “Global Urological Surgery Robots Market 2016-2025 by Application, Product, Equipment and Region” some of the major companies that are currently working in the global urological surgery robots market are AVRA Surgical Robotics, Inc., Medrobotics Corporation, MAKO Surgical Corp., SafeStitch Medical Inc., Dornier MedTech, Stryker, Blue Belt Technologies Ltd., Lumenis, Intuitive Surgical, Olympus, NovaTract Surgical, Inc., Boston Scientific, Medtronic Inc., Cook Medical, Titan Medical, Simbionix USA Corp., HealthTronics, Richard Wolf, Karl Storz, TransEnterix, Inc.
Based on the types of diseases, the global urological surgery robot market is segmented into prostate cancer, urinary incontinence, benign prostatic hyperplasia (BPH), urinary stones and other urological conditions. BPHis treated with laser therapy, transurethral needle ablation (TUNA), transurethral microwave thermotherapy (TUMT) as compared to transurethral resection of the prostate (TURP). Urinary stones are being controlled by less invasive cure options such as ureteroscopy and extra corporeal shock wave lithotripsy (ESWL) as compared to percutaneous nephrolithotomy (PCNL) & open surgery. Based on product, market can be breakdown into many endoscopes for instance ureteroscopes & nephroscopes, cystoscopes, robotic surgical systems, lithotripters, laser systems, brachytherapy systems, urodynamic systems, high intensity focused ultrasound (HIFU) systems and urology consumables.
Based on technology, market is categorized into EndoAssist, Automated Endoscopic System for Optimal Positioning (AESOP), the da Vinci Surgical System, ZEUS, Patient‐side cart, console and image-processing or insufficient stack. Additionally, based on application, market is defined as robotic partial nephrectomy, roboticureteral reimplantation, robotic sacrospinous suspension, robotic pyeloplasty (urinary reconstruction surgery), robotic retroperitoneal lymph node dissection, robotic cystectomy, robotic vesicovaginal fistula repair, robotic prostatectomy and robotic nephroureterectomy.
Some of the major associated benefits are reduced fatigue, no fulcrum effect, ergonomic positioning, enhanced degrees of freedom, 3-D visualization, elimination of tremor and motion scaling. Furthermore, some of the other major drawbacks include no tactile feedback, set-up times lengthy, expensive capital & running costs and reduced trainee experience.
The global urological surgery robots are primarily driven by the growing focus on MI surgeries. Some of the other driving factors are growth in the volume of prostatectomies, limitations in conventional surgeries, rising focus on emerging economies and increasing adoption of robotic surgeries. Apart from the driving factors the other major benefits include challenges associated are low penetration rates, shortage of skilled surgeons, availability of the alternative treatments for urology conditions, high equipment & maintenance costs and lack of clinical evidence affecting adoption. In addition, some of the other trends included in the adoption of micro & nano robots are increase in research & development (R & D) activities with increasing vendor focus on expansion of low cost robotic surgical systems.
Recently, robot assisted urological interventions have strained new prospects for safe & effective cure for urological diseases. Moreover, over the forecast period global urological surgery robots market to reach at US$3.33 billion, by 2025.
To know more, click on the link below:-
Global Urological Surgery Robots Market
Ankur Gupta, Head Marketing & Communications